Atlas Trials

Prognostic Significance of ctDNA in HL

Clinical trial NCT06263530 · RECRUITING

Trial details

NCT number
NCT06263530
Sponsor
Interni hematologicka klinika FNKV
Status
RECRUITING
Study type
OBSERVATIONAL
Prognostic Cancer Model
Start date
2022-01-02
Primary completion
2023-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.